CHMP's October Recommendations Include Venclyxto, Opdivo, Lucentis
Executive Summary
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) meets monthly to review applications for centralized EU marketing authorization. Here is a summary of their October recommendations.